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Abstract 
The secretions of molecules by cells are of tremendous interest for both fundamental insights 
studies and medical purposes. In this study, we propose a new biochip-based approach for 
the instantaneous monitoring of protein secretions, using antibody production by B 
lymphocytes cultured in vitro. This was possible thanks to the Surface Plasmon Resonance 
imaging (SPRi) of a protein biochip where antigen proteins (Hen Egg Lysozyme, HEL) were 
micro-arrayed along with series of control proteins. B cell hybridomas were cultured on the 
chip and the secretion of immunoglobulins (antibody) specific to HEL was monitored in real-
time and detected within only few minutes rather than after a 30-60 minutes incubation with 
standard ELISA experiments. This fast and sensitive detection was possible thanks to the 
sedimentation of the cells on the biochip sensitive surface, where local antibody 
concentrations are much higher before dilution in the bulk medium. An other interesting 
feature of this approach for the secretion monitoring was the independence of the SPR 
response -after normalization- regarding to the density of the surface-immobilized probes. 
Such biosensor might thus pave the way to new tools capable of both qualitative and semi-
quantitative analysis of proteins secreted by other immune cells. 
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1. Introduction 
Inter-cellular communication is of primary 
importance in any living multi-cellular organism. In 
the specific case of blood cells, the inter-cell 
signaling cascades are mainly mediated by the extra-
cellular secretion of proteins, which shall act as firing 
events for downstream cells (Hernandez-Fuentes et 
al. 2003), even though physical contact between 
cells may account in a much lesser extent. The 
monitoring of the secreting activity can be carried out 
either at the molecular level -by the labeling of 
soluble proteins followed by a colorimetric read-out 
(Enzyme-Linked Immunosorbent Assay, ELISA)- or 
at the cellular level by culturing cells on surface-
sensitive plates where cells are washed off before 
labeling on surface-captured secretions (ELISPOT) 
(Czerkinsky et al. 1983). Other techniques have 
been engineered to label individual cells -in solution- 
via their secreted products (Manz et al. 1995) thus 
enabling a flow cytometric analysis of cell 
hybridomas. Altogether, these approaches are based 
on end-point analysis, due to the labeling-washing 
steps prior to the readout, thus preventing any 
access to the kinetic insights of the secretion 
processes.  
The recent developments of micro-
technologies paved the way to cell-based analysis, 
where some biological activities can be monitored at 
the cellular level (El-Ali et al. 2006; Toner and Irimia 
2005). For instance, the secreting activities of blood 
cells are specially studied to give better insights of 
the immune responses (Hernandez-Fuentes et al. 
2003). To that end, biochips and biosensors 
dedicated to functional cell analysis are promising 
tools due to their reduced size, the access to 
parallelized assays and the small amounts of 
required biological starting material (Chen and Davis 
2006). With the aim of monitoring such events at the 
cellular level, the capture and characterization of 
fluorescently labeled lymphocytes have been 
developed on a miniaturized cytometry platform (Zhu 
et al. 2008a) whereas other studies were done on 
microarrays dedicated to the detection of cellular 
metabolites after labeling and read-out (Jones et al. 
2008; Zhu et al. 2008b).  
Surface Plasmon Resonance imaging 
(SPRi) is an optical technique suitable for label-free 
and real-time analysis of biomolecule interactions. 
SPR-based sensors have previously been used to 
detect interactions between many different types of 
molecules like DNA, peptide or protein (Grosjean et 
al. 2005; Guedon et al. 2000). More recently, this 
method was used to detect living cells (Hide et al. 
2002; Suraniti et al. 2007). In this way, Localized 
Surface Plasmon Resonance (LSPR) and Grating-
Coupled Surface Plasmon Resonance imaging 
(GCSPRi) allowed the label-free detection of specific 
cells or cellular metabolites (Endo et al. 2008; Jin et 
al. 2009). Although getting an increasing interest for 
a large variety of applications on biosensors, there 
are only few examples of SPR-based real-time 
monitoring of extra-cellular secretions. Peterson’s 
group described the culture of adherent cells 
deposited on a layer of fibronectin, coated with 
serum proteins. Although rather sensitive, such 
experiment did not allow the identification of the 
proteins secreted in the extra-cellular medium and 
precipitating on the sensor surface (Peterson et al. 
2009). Very recently, Stybayeva et al. presented a 
setup composed of two independent chambers, one 
dedicated to a subtype T cells capture and the other 
devoted to the cytokine SPR detection by flowing the 
culture medium collected from the first chamber 
(Stybayeva et al.). 
In the present work, we describe a protein 
microarray suitable for both on chip cells culture and 
simultaneous specific analysis of proteins secreted 
from hybridoma. As a proof of concept, murine B cell 
hybridoma secreting HEL-specific immunoglobulin G 
(IgG) were cultured on a chip where HEL-antigen 
was arrayed at different concentrations (along with 
negative controls to assess any non-specific signal). 
The multiplexed format of such microarray makes 
possible the simultaneous monitoring of the products 
secreted from a single culture well whose bottom is 
the SPR sensing surface, interacting with several 
specific probes (antigens) (Scheme 1). The SPRi 
detection allowed significant improvement of analysis 
times, by comparison with standard techniques such 
as ELISA, due to both the label-free process and the 
real-time monitoring of biological interactions at the 
vicinity of the cells. 
 
 
Scheme of the SPR imaging setup (A). Cells are 
loaded and cultured on a biochip where both antigen 
and control proteins have been electrochemically 
arrayed. Photograph of a gold-coated biochip (B). 
 
 
2. Materials and methods 
 
2.1. Reagents and chemicals 
 
 Cytochrome C, Bovine Serum Albumin 
(BSA), amino acids, Phosphate Buffer Saline (PBS), 
Penicillin and Streptomycin antibiotics were 
purchased from Sigma (Sigma-Aldrich, Saint 
Quentin-Falavier, France) as well as the culture 
media DMEM and RPMI, whereas the Fetal Bovine 
Serum (FSB) was from PAA Laboratoires (Les 
Mureaux, France). Pyrrole was purchased from 
Tokyo Casei (Japan), and was dissolved at a 1 M 
concentration in dry acetonitrile (Sigma) in a glove 
box. 3,3’,5,5’-tetramethylbenzidine (TMB) was 
purchased from Beckton Dickinson (BD Pharmingen, 
Pont de Claix, France), HEL lyophilized protein was 
from Merck (Paris, France). The Streptavidin-
Phycoerythrin used for the labeling of biotinylated 
molecules was from Invitrogen (Cergy Pontoise, 
France). The antibodies used as secondary agents -
peroxidase-conjugated rabbit anti-mouse antibody, 
goat biotinylated anti-mouse antibody- were obtained 
from Sigma. All chemicals were used without further 
purification. 
 
2.2. Biochip preparation 
 
Gold covered prisms (50 nm thick gold layer 
over a 2 nm thick chromium layer) (Scheme 1B) 
were provided by GenOptics (Horiba Scientific-
GenOptics, Orsay, France). Biochips were electro-
chemically arrayed with proteins as described 
elsewhere (Grosjean et al. 2005). Briefly, N-
hydroxysuccinimidyl 6-(pyrrolyl)-caproate (NHS-
pyrrole) was conjugated to proteins in PBS pH 7,4 
overnight at 4°C using NHS-pyrrole/protein molar 
ratio of 10. Conjugated proteins were then purified by 
ultracentrifugation on 3 kDa MWCO membranes and 
diluted at different concentrations (5, 10 and 20 µM) 
in a spotting buffer (50 mM phosphate buffer, 50 mM 
NaCl and 10 % glycerol, pH 6.8) containing 20 mM of 
free pyrrole. Proteins (HEL and Cytochrome C) were 
then grafted on the chip by electro-copolymerization 
of free pyrrole and pyrrole-modified protein (100ms, 
2V ddp).  
 
2.3. Cells culture 
 
The mouse hybridoma cell line F10 
producing monoclonal antibody anti-HEL (anti-Hen 
Egg Lysozyme) (Tello et al. 1993) was grown in 
DMEM supplemented with 10 % Fetal Bovine Serum 
(FBS), non-essential amino acids (0.1 mM), sodium 
pyruvate (1 mM), 50 μM 2-mercaptoethanol, 50 U/mL 
Penicillin and 50 µg.mL-1 Streptomycin. The cultures 
were incubated at 37°C in a humidified (95 %) and 
5 % CO2 incubator. Cells were centrifuged 5 minutes 
at 200 g prior to the experiments and cell pellets 
were re-suspended at 5.105 cells.mL-1 in serum-free 
RPMI medium buffered with HEPES at 28 mM.  
 
2.4. ELISA titration of secreted anti-HEL IgG  
 
The secreting activities of cells used during 
SPRi experiments were characterized by ELISA 
assays. Aliquots (1mL) of cellular suspension were 
incubated at 37°C in 24-well plates. At different 
incubation times, the supernatant was collected and 
anti-HEL IgG secreted by the cells was quantified by 
ELISA according to standard protocols (Villiers et al. 
1993). Briefly, the plates were coated with HEL 
(10 µg.mL-1 in PBS) for 2h at 37°C. Bound antibodies 
were revealed with peroxidase-conjugated rabbit 
anti-mouse IgG (1/20,000) using TMB as substrate. 
Standard curves were plotted using calibrated 
solutions of monoclonal anti-HEL antibody purified 
from F10 cell line supernatants. 
 
2.5 SPRi detection of antibody secretion 
 
Cell incubations were carried out at 37°C in 
a PEEK culture well fitting the micro-arrayed face of 
the biochip (Scheme 1). After saturation of the chip 
surface with RPMI supplemented with 10 % FBS, 
hybridoma B-cells, suspended in serum-free 
medium, were loaded into the well and their 
secreting activity was monitored by SPRi. Cells are 
not specifically bound on the biosensor surface but 
only loaded as a cells suspension. Then, cells 
quickly sediment on the surface (within few minutes) 
and thus get in the immediate vicinity of the grafted 
probes. Protein-protein interactions between 
secreted IgG and the sensor-grafted antigens 
induced variations of the refractive index near the 
gold surface, and thus triggering changes in reflected 
light intensities monitored using a 12-bit CCD 
(Guedon et al. 2000). The regions of interest were 
defined as spots areas where electropolymerization 
occurred. The mean feature size is about 300 µm in 
diameter. The signal of every pixel included into this 
area was recorded, averaged with the other pixels of 
the same region of interest and plotted.  
 
2.6 Fluorescent detection of antigen-antibody 
interactions 
 
After the SPRi experiment was completed, 
the biochip was removed from the SPR imager and 
gently washed with PBS. F10 anti-HEL antibodies 
bound to the chip were labeled with a biotinylated 
anti-mouse antibody (10 minutes incubation at room 
temperature), followed by a Streptavidin-
Phycoerythrin conjugation step (10 % dilution in 
PBS, 5 minutes incubation). The fluorescent labeling 
of the spots was observed using an epi-fluorescence 
microscope (BX, Olympus) equipped with a Peltier-
cooled CCD camera (Hamamatsu, Japan). 
 
 
3. Results and discussion 
 
The mouse F10 hybridoma cell line was 
chosen for its ability to permanently secrete 
monoclonal anti-HEL antibodies. Biochips were thus 
functionalized with the HEL (antigen) along with 
cytochrome C which was chosen as a negative 
control due to a molecular weigh close to that of HEL 
protein. The microarraying of probe molecules was 
carried out by a localized electropolymerization of the 
proteins (spots c.a. 300 µm in diameter) on a gold 
covered biochip (Grosjean et al. 2005). In such 
configuration, the gold film was used as a working 
electrode where both HEL-pyrrole conjugates (in 
solution at 5, 10 and 20 µM concentrations) and 
cytochrome C-pyrrole conjugates (20 µM) could be 
grafted at different locations. Before the SPR 
imaging, cells were centrifuged and suspended in 
fresh culture medium to discard any anti-HEL 
antibodies secreted prior to the on-chip incubation. 
The cellular suspension was then loaded in a culture 
well designed to fit the biochip functionalized surface 
(Scheme 1). Binding between anti-HEL antibody -
secreted from cells contained in a single well- and 
HEL proteins grafted on the chip at different 
concentrations could be simultaneously detected by 
SPRi (Figure 1A). By choosing an antigen protein 
(HEL, about 15 kDa) as a probe recognized by an 
immunoglobulin G (about 150 kDa), we are in a 
favorable configuration for a sensitive target 
detection. The kinetics of cellular secretions released 
in the extra-cellular medium were recorded in real-
time for eight hours by SPRi. Some discrete objects 
appeared randomly on HEL spots, corresponding to 
individual cells bound on the surface. This rare 
background response might be due to the presence 
of antibodies specific to the HEL antigen and bound 
to the cell membrane. Pixels intensities of these 
objects were monitored and were shown to not 
significantly affect the overall spot pixel averaging, 
with a contribution lower than five percent whatever 




Figure 1: SPR image of a biochip arrayed with HEL 
(0, 5, 10 or 20 µM) after different incubation times 
with anti-HEL antibody secreting cells (A). The 0 µM 
HEL spot corresponds to a cytochrome C control 
spot (20 µM, ) where no HEL was grafted. 
Fluorescence image of the same spots observed by 
fluorescence microscopy after the SPR imaging 
experiment (B). Surface-bound anti-HEL antibodies 
were conjugated with anti-mouse IgG (Fc specific) 
and stained with Streptavidin-Phycoerythrin. 
 
After incubation, surface bound proteins 
were fluorescently labeled by counter-staining of the 
mouse anti-HEL IgG with a goat anti-mouse antibody 
conjugated with biotin and followed by a Streptavidin-
Phycoerythrin recognition (Figure 1B). The much 
lower background signal observed on the end-point 
analysis is due to the molecular sandwich set-up 
where only target molecules bound to the surface are 
labeled by a secondary antibody specific to the HEL-
immunoglobulin.  
Reflectivity variations of the HEL-grafted 
spots were plotted upon time by averaging the grey 
level of each pixel contained in a region of interest 
matching each individual spot. The plotted curves 
confirmed the highly specific recognition between 
antibodies and antigens detected only few minutes 
after cells loading in the culture well (Figure 2A). 
Once again, the specificity of the reaction was 
checked thanks to the cytochrome C control spots 
where no reflectivity drift could be observed thus 
assessing both the highly specific detection of anti-
HEL antibodies and a low background adsorption on 
control proteins. The background subtraction 
explains the differences of grey level images 
observed on the SPR images on figure 1A versus the 
curves plotted in figure 2A : even though the overall 
reflectivity level may drift upon time, subtraction of 
non-specific response (on polypyrrole spot) to the 
negative control cytochrome C spot exhibit only a 
weak variation during the time lap of the experiment.  
 
Figure 2: SPR monitoring of the reflectivity variations 
upon the incubation time. The biochip was arrayed 
with different spots polymerized with either 
cytochrome C 20 µM (gray dotted line), HEL 5 µM 
(light gray line), 10 µM (dark gray line) or 20 µM 
(black line) solutions (A). The concentrations refer to 
the concentration of the proteins in the solution 
prepared for the electrochemical polymerization of 
polypyrrole films on the biochip. Cells were loaded 
on chip at time 0. The background signal 
corresponding to the unspecific response registered 
on polypyrrole spots was subtracted to the signal 
registered on the spots of interest. ELISA titration of 
anti-HEL antibodies contained in cellular 
supernatants after different incubation times (B). 
 
Enzyme-linked Immunosorbent assay 
(ELISA) was used as a reference technique for the 
titration of antibody secretion. We exploited this end-
point colorimetric assay to compare the limits of 
detection (in terms of time required for the 
assessment of protein secretion) with SPR imaging 
performances. F10 hybridoma cells suspended in 
culture medium were loaded in multi-well plates and 
cultured at 37°C to ensure the anti-HEL secretion. 
On the contrary to SPR imaging where the detection 
occurs simultaneously with the cellular secretion 
(real-time monitoring), ELISA protocol requires the 
collection of sample aliquots for further labeling and 
titration (end-point analysis). Cellular supernatants 
were then collected at different incubation times and 
titrated according to standard ELISA protocols. 
Calibrated solutions of purified F10 anti-HEL 
antibody were used to get quantitative values of 
secreted antibodies. After a 30 minutes incubation, 
the concentration of IgG released in the supernatant 
was 51.3 ± 5.6 ng.mL-1 and increased linearly with 
time, reaching a concentration of 579.1 ± 47.7 ng.ml-
1 after eight hours of incubation (Figure 2B). 
The SPRi curves, unlike the ELISA curve, 
showed a sharp signal increase for short incubation 
times (within one hour), with a significant response 
obtained faster than using ELISA test. In a second 
phase, the SPRi slopes decreased and reached a 
plateau. The three different observed plateaus were 
dependent on the concentration of monomer 
solutions used for probe grafting and reflect the 
saturation of grafted probes. Interestingly, by 
normalizing SPR kinetic curves against the different 
saturation plateau levels, we observed the perfect 
overlay of the curves whatever the concentration of 
probe antigens (see supplemental data). All the 
curves followed a linear dependency between time 
and reflectivity variation for short incubation times 
(less than one hour) and an exponential variation for 
longer incubation. A characteristic time value was 
extracted from the modeling of this data, and was 
shown to be consistent with independent ELISA 
experiments run in triplicate. More importantly, this 
characteristic time was shown to be independent on 
the density of grafted probes -in the range of grafted 
molecules shown here- but rather specific to the 
secretion phenomenon. 
Although the typical detection limit of 
biomolecular interactions using SPR is in the 
nanomolar range (Scarano et al.), our approach 
showed significant improvements for the detection of 
secreted antibodies below nanomolar 
concentrations: focusing on the data acquired after 
an half-hour incubation, the ELISA titration 
evidenced an anti-HEL antibody concentration of 
about 50 ng.mL-1, corresponding to 0.35 nM in bulk 
medium, whereas SPR data showed a strong signal 
after only few minutes of incubation. Control SPR 
imaging experiment have been carried on with anti-
HEL antibodies at calibrated concentrations in the 
nanomolar range, and no significant response could 
be monitored (data not shown). Such results confirm 
the efficiency of this technique for the secretion 
detection in the close vicinity of the cell, rather than 
the detection of target molecules dissolved in the 
bulk medium (ELISA assays). This significant 
increase in sensitivity is mainly due to our 
experimental approach where living secreting cells 
are directly loaded onto the biochip and gently 
settled on the sensing surface. Because the SPR 
phenomenon is sensitive to any optical index change 
within few hundreds of nanometer above the gold 
layer, we were capable to explore the secretions in 
the intimate vicinity of the cells. Such focus on the 
direct environment of the cell gives access to locally 
high concentrations of secreted products which 
triggers a significant shift in the reflected light 
intensities. Besides this noticeable improvement of 
the limits of detection for cell secretion monitoring, 
the real-time detection drastically improves the time 
needed for the sample processing. Such shortening 
of the sample treatment time is possible thanks to 
the monitoring of the cells as they are secreting the 
molecules of interest, which is not the case with any 
label-based technique such as ELISA or ELISPOT 




As a conclusion, we have successfully built 
a biochip suitable for the SPR based detection of 
cellular secretions. We have shown the interest of 
such cell-based technique to follow, in real-time, 
cellular secretions as the reflectivity variation 
detected within few minutes was shown to be 
specific to the secreting event, rather than to the 
grafted probe density. Besides a significant 
improvement of the processing time required by 
other conventional techniques, this approach saves 
several experimental steps (collection of cell 
suspensions, immuno-staining, washing and 
eventually colorimetric labeling and read-out), and 
does not require any labeling step involved in most 
other end-point techniques. Such improvements 
were possible by taking advantage of the 
evanescent-wave depth to explore the extra-cellular 
medium surrounding cells settled on the biochip 
surface. For the first time, we propose a one-step 
label-free method able to detect, in real time, 
secreting activities of living non-adherent cells 
cultured on a biochip. Moreover, the miniaturized 
sensor shows a great flexibility and is suitable for 
multi-target detection as several probes can be 
arrayed in a single biochip. The simultaneous 
analysis of different secreted products is currently in 
progress with primary cells capable of complex 
proteins secretion. This quick and easy method could 
provide a very useful tool for cellular phenotype 
analysis in different fields such as immunology where 
secreting activities are key biological events in the 
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